Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
nitroglycerin
NITROglycerin
- Formulary NITROglycerin Patch Formulary
- Formulary Nitrates Formulary
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Nitro-Time | CAPSULE, EXTENDED RELEASE, ORAL | 2.5 mg, 6.5 mg, 9 mg | ||||
| Minitran | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.1 mg/hr, 0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr | ||||
| Nitro-Dur | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.1 mg/hr, 0.2 mg/hr, 0.3 mg/hr, 0.4 mg/hr, 0.6 mg/hr | ||||
| Transderm-Nitro | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.1 mg/hr, 0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr | ||||
| Deponit | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.2 mg/hr, 0.4 mg/hr | ||||
| Nitrodisc | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.2 mg/hr, 0.3 mg/hr, 0.4 mg/hr | ||||
| Nitrocine | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.6 mg/hr | ||||
| Rectiv | OINTMENT, RECTAL | 0.4% | ||||
| Nitro-Bid | OINTMENT, TRANSDERMAL | 2% | ||||
| GoNitro | POWDER, ORAL | 400 mcg | ||||
| Nitroglycerin | SOLUTION, INTRAVENOUS | 5 mg/mL | ||||
| Nitroglycerin | SOLUTION, INTRAVENOUS | 50 mg/250 mL | ||||
| Nitroglycerin | SOLUTION, INTRAVENOUS | 200 mcg/mL, 400 mcg/mL | ||||
| Nitrolingual | SPRAY, SUBLINGUAL | 0.4 mg | ||||
| Nitromist | SPRAY, SUBLINGUAL | 0.4 mg | ||||
| Nitroquick, Nitrostat | TABLET, SUBLINGUAL | 0.3 mg, 0.6 mg | ||||
| Nitrostat | TABLET, SUBLINGUAL | 0.4 mg |
Last updated: Nov. 14, 2025
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NITROglycerin (Deponit)
NITROglycerin (GoNitro)
NITROglycerin SL
NITROglycerin (Minitran)
NITROglycerin (Nitro-Dur)
NITROglycerin (Nitrocine)
NITROglycerin (Nitrodisc)
NITROglycerin(Nitro-Dur)
NITROglycerin (Nitromist)
NITROglycerin (Nitrolingual)
NITROglycerin ER (Nitro-Time)
isosorbide mononitrate SR (Imdur)
NITROglycerin (Transderm-Nitro)
NITROglycerin(Nitro-Dur)
NITROglycerine Patch Standard Times – To reduce tolerance, it is generally recommended that NITROglycerine patches be applied for no longer than 12 – 14 hours a day, with a 10 – 12 hour patch-free period. It was approved for a standard administration time to be 9 am, and removal time to be 9 pm. If an order is received prior to 7 pm, the patch would be applied until 9 pm and then removed, and re-applied at 9 am the next day. If the order is processed at 7 pm or after, the dose should be deferred until the next morning. Now orders will be dispensed as written.
Nitromist (NITROglycerin spray) is classified as non-formulary, not stocked. Dispense formulary NITROglycerin spray product (Nitrolingual).
Rectiv is classified as non-formulary, not stocked. Defer initiation to the outpatient setting. If judged necessary, the patient may use his/her own supply while in the hospital.
Nitro-Time (NITROglycerin ER) is classified as non-formulary, not stocked. Automatic interchange to Imdur.
Nitroglycerin 0.6 mg SL tablets are restricted to Heart Center drug stock for use in CT scanning areas. Inpatient orders for will be automatically interchanged to the nitroglycerin 0.4 mg SL tablet.
Reviewed: August 28, 2007 (Nitromist), August 26, 2008 (Nitrates, Oral Formulary), March 27, 2012 (Rectiv), 13 December 2016 (GoNitro)
Updated: 22 March 2016 (Nitro-Time), October 2025 (Nitrostat)
Heart Center Floor Stock Update Nitroglycerin SL SBAR.pdf